261 related articles for article (PubMed ID: 34762752)
1. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
Sasaki T; Akiyama M; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2022 Feb; 61(2):490-501. PubMed ID: 34363463
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.
Nishimura MF; Igawa T; Gion Y; Tomita S; Inoue D; Izumozaki A; Ubara Y; Nishimura Y; Yoshino T; Sato Y
J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33321725
[TBL] [Abstract][Full Text] [Related]
4. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease.
Kawanishi M; Kamei F; Sonoda H; Oba M; Fukunaga S; Egawa M; Koyama T; Sato Y; Tanabe K; Ito T
CEN Case Rep; 2023 May; 12(2):242-248. PubMed ID: 36414812
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
[TBL] [Abstract][Full Text] [Related]
8. [Pathological significance of plasma cell infiltration in diagnosing lymph node diseases].
Hu H; Jiang YJ; Xu L; Yin LJ; Liu XF; Yin SY; Xu JJ; He MX
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):702-709. PubMed ID: 37408401
[No Abstract] [Full Text] [Related]
9. From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.
Rodriguez Merino L; Pomares AA; Arce JR; Montes-Moreno S
J Clin Pathol; 2024 Apr; 77(5):318-323. PubMed ID: 36690434
[TBL] [Abstract][Full Text] [Related]
10. Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports.
Zoshima T; Yamada K; Hara S; Mizushima I; Yamagishi M; Harada K; Sato Y; Kawano M
Am J Surg Pathol; 2016 Apr; 40(4):495-501. PubMed ID: 26598921
[TBL] [Abstract][Full Text] [Related]
11. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
12. IgG4-related respiratory disease.
Matsui S
Mod Rheumatol; 2019 Mar; 29(2):251-256. PubMed ID: 30474465
[TBL] [Abstract][Full Text] [Related]
13. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice.
Mizushima I; Yamano T; Kawahara H; Hibino S; Nishioka R; Zoshima T; Hara S; Ito K; Fujii H; Nomura H; Kawano M
Rheumatology (Oxford); 2021 Jul; 60(7):3317-3325. PubMed ID: 33313857
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease.
Satou A; Notohara K; Zen Y; Nakamura S; Yoshino T; Okazaki K; Sato Y
Pathol Int; 2020 Jul; 70(7):391-402. PubMed ID: 32314497
[TBL] [Abstract][Full Text] [Related]
15. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
[TBL] [Abstract][Full Text] [Related]
16. Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases.
Otoshi R; Kitamura H; Baba T; Muraoka T; Sekine A; Takemura T; Okudela K; Sawazumi T; Ogura T
Respir Investig; 2024 Jan; 62(1):1-8. PubMed ID: 37925882
[TBL] [Abstract][Full Text] [Related]
17. [Hyper-IL-6 syndrome mimicking IgG4-related disease].
Terao T; Yamamoto K; Ikeuchi K; Wakabayashi H; Igawa T; Inoue D; Oda W; Oyama T; Kamoi C; Sumii Y; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Sato Y; Yoshino T; Imajo K
Rinsho Ketsueki; 2019; 60(5):392-397. PubMed ID: 31168001
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Zen Y
Presse Med; 2020 Apr; 49(1):104014. PubMed ID: 32234381
[TBL] [Abstract][Full Text] [Related]
20. Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease.
Han Y; Igawa T; Ogino K; Nishikori A; Gion Y; Yoshino T; Sato Y
J Clin Exp Hematop; 2020 Mar; 60(1):1-6. PubMed ID: 32037354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]